Exchange Execs Cast Doubt on Mifid II's Best-Ex Reports

Experts warn venue reports will be unreliable and effectively bereft of value for investors.

Stock Chart
Getty

Under the revised Markets in Financial Instruments Directive and Regulation (Mifid II), trading venues, systematic internalizers and market-makers are required to disclose details on execution quality for trades that take place on their order books. Regulatory technical standard (RTS) 27 covers this, while RTS 28 requires firms to list their top execution venues and disclose how they achieved quality execution for clients. Collectively, these RTS represent a shift change in how best execution is

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

CME: CFTC OKs clearing move to Google Cloud

The CFTC has given the Chicago-based exchange approval to run its clearing and settlement infrastructure on the Google Cloud Platform, while the exchange and vendor have extended their partnership to last until at least 2037.

Cutting through the hype surrounding the FDTA rulemaking process

A bill requiring US regulators and institutions to adopt a machine-readable data framework for reporting purposes applies to entity identifiers, but not security identifiers, in a crucial difference, writes Scott Preiss, SVP and global head of Cusip Global Services.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here